Selective Down-Regulation of Nuclear Poly(ADP-Ribose) Glycohydrolase
David Burns(Hospital for Special Surgery), Raymond A. Swanson(San Francisco VA Medical Center)
Cited by 19
Related Papers
Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseases
|British Journal of Pharmacology|2017|210
Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration
|Nature Immunology|2018|210
Hypoglycemic Neuronal Death and Cognitive Impairment Are Prevented by Poly(ADP-Ribose) Polymerase Inhibitors Administered after Hypoglycemia
|Journal of Neuroscience|2003|206
Nuclear Factor Erythroid 2-Related Factor 2 Facilitates Neuronal Glutathione Synthesis by Upregulating Neuronal Excitatory Amino Acid Transporter 3 Expression
|Journal of Neuroscience|2011|96
Brain energy metabolism: A roadmap for future research
|Journal of Neurochemistry|2024|94